We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Expands Safety Guidance for Developing Anticancer Drugs
EMA Expands Safety Guidance for Developing Anticancer Drugs
The European Medicines Agency adopted the fifth revision of its substantive guideline covering all stages of oncology drug development, expanding upon the previous version’s section on safety data.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor